We are excited to announce an open call for high-impact research articles for our special issue on Nanomedicines, from thorough characterization to in vivo evaluation. As nanomedicine continues to transform diagnostics, therapeutics, and personalized medicine, we seek cutting-edge contributions that address both the scientific breakthroughs and the challenges facing this rapidly evolving field. This special issue is dedicated to the topics presented in the 11th annual conference of the French Society of Nanomedicine (https://www.sfnano.fr) presented in Lyon, France (24-26 November 2025).
Authors are encouraged to submit original research, comprehensive reviews, and insightful perspectives on topics including—but not limited to— new approaches for nanomedicine (Cancer, Immunity), Imaging and diagnostics and theranostics, chemistry and characterization of nanomaterials and translational work from bench to market.
All manuscripts will undergo a rigorous peer-review process to ensure high scientific standards. By sharing your work, you will contribute to a global dialogue that accelerates the translation of nanomedicine from bench to bedside. Join us in shaping the future of healthcare through nanotechnology. We look forward to your innovative contributions!
To submit a paper to this Special Issue, please go to https://www.editorialmanager.com/ijpharmx/default2.aspx and select the article type “VSI: SFNANO 2025”.
The submission deadline is June 30, 2026.